ITGB3 and osteosarcoma: To elucidate the underlying mechanism of the anti‐cisplatin effect of ITGB3 in osteosarcoma, we collected total RNA and performed transcriptome analysis on 143B (WT), ITGB3‐KO (KO), cisplatin‐treated 143B (Cis_WT) and ITGB3‐KO (Cis_KO) cells.